Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 528-536

  Komsuoglu Celikyurt, Ipek ^a   Kayir, Hakan ^b   Ulak, Guner ^a   Erden, Faruk B ^a   Ulusoy, Gokhan K ^b   Uzbay, Tayfun I ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ethanol withdrawal; Quetiapine; Rat(s); Risperidone; Ziprasidone

Indexed keywords

ALCOHOL; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT ANIMAL; AGITATION; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; CONTROLLED STUDY; DIET; DRUG EFFICACY; GAIT DISORDER; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; RAT; SEIZURE; STEREOTYPY; WEIGHT GAIN;

ALCOHOLISM; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BODY WEIGHT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COMORBIDITY; DIBENZOTHIAZEPINES; ETHANOL; HUMANS; HYPERKINESIS; MALE; MOTOR ACTIVITY; PIPERAZINES; PSYCHOMOTOR AGITATION; RATS; RATS, WISTAR; RISPERIDONE; SCHIZOPHRENIA; SUBSTANCE WITHDRAWAL SYNDROME; THIAZOLES; TIME FACTORS;

EID: 79952898758     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.12.009     Document Type: Article

References (62)

1. Alldregge B.K. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999, 53(Suppl 2):S68-S75.
2. Batel P. Addiction and schizophrenia. Eur Psychiatry 2000, 15:15-122.
3. Ciccocioppo R. The role of serotonin in craving: from basic research to human studies. Alcohol 1999, 34:244-253.
4. Conroy S.K., Rodd Z., Chambers R.A. Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats. Pharmacol Biochem Behav 2007, 86:386-394.
5. Dall'Olio R., Gandolfi O., Vaccheri A., Roncada P., Montanaro N. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats. Psychopharmacology 1988, 95:381-385.
6. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995, 38:95-137.
7. Drake R.E., Xie H., McHugo G.J., Green A.I. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 2000, 26:441-449.
8. D'Souza D.C., Gil R.B., Madonick S., Perry E.B., Forselius-Bielen K., Braley G., et al. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology 2006, 31:2767-2775.
9. Feldman D.J., Frank R.A., Kehne J.H., Flannery R., Brown D., Soni S., et al. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior. Pharmacol Biochem Behav 1997, 58:565-572.
10. Gerald M.C., Richter N.A. Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacologia 1976, 46:277-282.
11. Hambrecht M., Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996, 40:1155-1163.
12. Hedges D., Jeppson K., Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today 2003, 39:551-557.
13. Heilig M., Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanism. Pharmacol Ther 2006, 111:855-876.
14. Heimer L., Alheid G.F., de Olmos J.S., Groenewegen H.J., Haber S.N., Harlan R.E., et al. The accumbens: beyond the core-shell dichotomy. J Neuropsychiatry Clin Neurosci 1997, 9:354-381.
15. Helzer D., Pryzbeck T.R. The co-occurence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988, 49:219-224.
16. Hutchison K.E., Wooden A., Swift R.M., Smolen A., McGeary J., Adler L., et al. Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 2003, 28:1882-1888.
17. Ingman K., Honkanen A., Hyytiä P., Hattunen M.O., Korpi E.R. Risperidone reduces limited access alcohol drinking in alcohol-preferring rats. Eur J Pharmacol 2003, 468:121-127.
18. Jaffe J.H. Drug addiction and drug abuse. Goodman and Gilman's The pharmacological basis of therapeutics 1990, 522-573. Pergamon Press, New York. A.G. Gilman, T.W. Rall, A.S. Wies (Eds.).
19. Kayir H., Uzbay T. Effects of clozapine on ethanol withdrawal syndrome in rats. Alcohol Alcohol 2008, 43:619-625.
20. Kuriyama K., Ohkuma S. Alterations in the function of cerebral neurotransmitter receptors during the establishment of alcohol dependence: neurochemical aspects. Alcohol Alcohol 1990, 25:239-249.
21. Lal H., Prather P.L., Rezazadeh S.M. Potential role of 5-HT1C and/or 5-HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 1993, 17:411-417.
22. Larue-Achagiotis C., Poussard A.M., Louis-Sylvestre J. Alcohol drinking, food and fluid intakes and body weight gain in rats. Physiol Behav 1990, 47:545-548.
23. Le Marquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse, dependence: clinical evidence. Biol Psychiatry 1994, 36:326-337.
24. Longoni R., Spina L., Di Chiara G. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats. Life Sci 1987, 41:2135-2145.
25. Magnusson O., Fowler C.J., Köhler C., Ogren S.O. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs. Neuropharmacology 1986, 25:187-197.
26. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 1975, 43:1993-1996.
27. Martinotti G., Andreoli S., Di Nicola M., Di Gianantonio M., Sarchiapone M., Janiri L. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 2008, 23:417-424.
28. Meltzer H.Y. Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 1995, 3:64-75.
29. Mirowsky Y., Wagner G.C., Sekowski A., Goldberg M., Fisher H. Simultaneous changes in striatal dopamine, serotonin, and their metabolites after withdrawal seizures in rats from dependence on alcohol. Alcohol 1995, 12:251-256.
30. Murphy J.M., McBridge W.J., Lumeng L., Li T.-K. Contents of monoamines in forebrain regions of alcohol-preferring and nonpreferring lines of rats. Pharmacol Biochem Behav 1987, 26:389-392.
31. Myers R.D., Martin G.E. The role of cerebral serotonin in the ethanol preference of animals. Ann NY Acad Sci 1973, 215:135-144.
32. Nasrallah H.A. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding properties. Mol Psychiatry 2008, 13:27-35.
33. Noble E. The gene that rewards alcoholism. Sci Am Sci Med 1996, 3:52-61.
34. Overstreet D.H., Knapp D.J., Moy S.S., Breese G.R. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology 2003, 167:344-352.
35. Overstreet D.H., Knapp D.J., Angel R.A., Navarro M., Breese G.R. Reduction in repeated ethanol- withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. Psychopharmacology 2006, 187:1-12.
36. Parale M.P., Kulkarni S.K. Studies with alpha-2 adrenoceptor agonists and alcohol abstinence syndrome in rats. Psychopharmacology 1986, 88:237-239.
37. Potvin S., Stip E., Roy J.Y. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. Int Clin Psychopharmacol 2003, 18:121-132.
38. Regier D., Farmer M., Rae D., Locke B., Keith S., Judd L. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. J Am Med Assoc 1990, 264:2511-2518.
39. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993, 18:247-291.
40. Roy A., Virkunnen M., Linnolia M. Reduced central serotonin turnover in subgroup of alcoholics. Biol Psychiatry 1987, 11:173-177.
41. Schatzberg A.F., Cole J.O., DeBattista C. Manuel of clinical pharmacology 2003, 159-244. American Psychiatric Publishing Inc, Washington DC. 4th ed.
42. Schuckit M.A. Recent developments in the pharmacotherapy of alcohol dependence. J Consult Clin Psychol 1996, 64:669-676.
43. Seeman P., Schwarz J., Chen J.F., Szechtman H., Perreault M., McKnight G.S., et al. Psychosis pathways converge via D2 high dopamine receptors. Synapse 2006, 60:319-349.
44. Semenova T.P., Tiku M.K. Interactions between the serotoninergic and noradrenergic systems of the brain and their role in the regulation of animal behavior. Neurosci Behav Physiol 1997, 27:280-282.
45. Stefan M., Travis M., Murray R.M. An atlas of schizophrenia 2002, 74-77. The Parthenon Publishing Group, London.
46. Sturman G., Freeman P., Quinn L. Histamine H1-antagonists potentiate seizures in the EL (epilepsy-like) mouse model of temporal lobe epilepsy. Inflamm Res 2001, 50(Suppl. 2):S80-S81.
47. Thrasher M.J., Freeman P.A., Risinger F.O. Clozapine's effects on ethanol's motivational properties. Alcohol Clin Exp Res 1999, 23:1377-1385.
48. Trzaskowska E., Krzascik P., Staniszewska A., Pucilowski O., Kostowski W. On the relative importance of D-1 vs. D-2 dopaminergic receptors in the control of audiogenic seizures in ethanol withdrawn rats. Drug Alcohol Depend 1989, 24:265-267.
49. Unsalan N., Saglam E., Kayir H., Uzbay I.T. Effects of olanzapine on ethanol withdrawal syndrome in rats. Eur J Pharmacol 2008, 579:208-214.
50. Uzbay I.T. Serotonergic antidepressants and ethanol withdrawal syndrome: a review. Alcohol Alcohol 2008, 43:15-24.
51. Uzbay I.T., Erden B.F. Attenuation of ethanol withdrawal signs by high doses of l-arginine in rats. Alcohol Alcohol 2003, 38:213-218.
52. Uzbay I.T., Kayaalp S.O. A modified liquid diet of chronic ethanol administration: validation by ethanol withdrawal syndrome in rats. Pharmacol Res 1995, 31:37-42.
53. Uzbay I.T., Akarsu E.S., Kayaalp S.O. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol Biochem Behav 1994, 49:969-974.
54. Uzbay I.T., Erden B.F., Tapanyiǧit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 1997, 61:2197-2209.
55. Uzbay I.T., Usanmaz S.E., Tapanyigit E.E., Aynacioglu S., Akarsu E.S. Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs. Drug Alcohol Depend 1998, 53:39-47.
56. Uzbay I.T., Usanmaz S.E., Akarsu E.S. Effects of chronic ethanol administration on serotonin metabolism in the various regions of the rat brain. Neurochem Res 2000, 25:257-262.
57. Uzbay I.T., Yesilyurt O., Celik T., Ergun H., Isimer A. Effects of agmatine on ethanol withdrawal in rats. Behav Brain Res 2000, 107:153-159.
58. Uzbay I.T., Saglam E., Kayir H., Çelik T., Beyazyurek M. Effects of fluoxetine on ethanol withdrawal syndrome in rats. J Psychiatr Res 2004, 38:445-450.
59. Uzbay I.T., Çelik T., Aydin A., Kayir H., Tokgöz S., Bilgi C. Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3', 5'-monophosphate (cGMP) levels in the rat brain. Drug Alcohol Depend 2004, 74:55-59.
60. Vergne D.E., Anton R.F. Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets 2010, 9:50-54.
61. Walker B.M., Rasmussen D.D., Raskind M.A., Koob G.F. Alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 2008, 42:91-97.
62. Yu L., Fisher H., Wagner G.C. Monoaminergic changes associated with audiogenic seizures in ethanol-dependent rats. Prog Neuropsychopharmacol Biol Psychiatry 2000, 24:1379-1392.